The	the	O	O	O	O
risk	risk	O	O	O	O
of	of	O	O	O	O
venous	venous	O	DISEASE	OTHERS	I
thromboembolism	thromboembolism	O	DISEASE	OTHERS	I
in	in	O	O	O	O
women	women	O	O	O	O
prescribed	prescribed	O	O	O	O
cyproterone	cyproterone	CHEMICALS	O	OTHERS	I
acetate	acetate	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
combination	combination	O	O	O	O
with	with	O	O	O	O
ethinyl	ethinyl	CHEMICALS	O	OTHERS	I
estradiol	estradiol	CHEMICALS	O	OTHERS	I
:	:	O	O	O	O
a	a	O	O	O	O
nested	nested	O	O	O	O
cohort	cohort	O	O	O	O
analysis	analysis	O	O	O	O
and	and	O	O	O	O
case-control	case-control	O	O	O	O
study	study	O	O	O	O
.	.	O	O	O	O

BACKGROUND	background	O	O	O	O
:	:	O	O	O	O
Cyproterone	cyproterone	CHEMICALS	O	OTHERS	I
acetate	acetate	CHEMICALS	O	OTHERS	I
combined	combined	O	O	O	O
with	with	O	O	O	O
ethinyl	ethinyl	CHEMICALS	O	OTHERS	I
estradiol	estradiol	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
CPA/EE	cpa/ee	O	O	O	O
)	)	O	O	O	O
is	is	O	O	O	O
licensed	licensed	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
UK	uk	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
treatment	treatment	O	O	O	O
of	of	O	O	O	O
women	women	O	O	O	O
with	with	O	O	O	O
acne	acne	O	DISEASE	OTHERS	I
and	and	O	O	O	O
hirsutism	hirsutism	O	O	OTHERS	I
and	and	O	O	O	O
is	is	O	O	O	O
also	also	O	O	O	O
a	a	O	O	O	O
treatment	treatment	O	O	O	O
option	option	O	O	O	O
for	for	O	O	O	O
polycystic	polycystic	O	DISEASE	OTHERS	I
ovary	ovary	O	DISEASE	OTHERS	I
syndrome	syndrome	O	DISEASE	OTHERS	I
(	(	O	O	O	O
PCOS	pcos	O	DISEASE	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

Previous	previous	O	O	O	O
studies	studies	O	O	O	O
have	have	O	O	O	O
demonstrated	demonstrated	O	O	O	O
an	an	O	O	O	O
increased	increased	O	O	O	O
risk	risk	O	O	O	O
of	of	O	O	O	O
venous	venous	O	DISEASE	OTHERS	I
thromboembolism	thromboembolism	O	DISEASE	OTHERS	I
(	(	O	O	O	O
VTE	vte	O	DISEASE	OTHERS	I
)	)	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
CPA/EE	cpa/ee	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
conventional	conventional	O	O	O	O
combined	combined	O	O	OTHERS	I
oral	oral	CHEMICALS	O	OTHERS	I
contraceptives	contraceptives	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
COCs	cocs	O	O	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
believe	believe	O	O	O	O
the	the	O	O	O	O
results	results	O	O	O	O
of	of	O	O	O	O
those	those	O	O	O	O
studies	studies	O	O	O	O
may	may	O	O	O	O
have	have	O	O	O	O
been	been	O	O	O	O
affected	affected	O	O	O	O
by	by	O	O	O	O
residual	residual	O	O	O	O
confounding	confounding	O	O	O	O
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
Using	using	O	O	O	O
the	the	O	O	O	O
General	general	O	O	O	O
Practice	practice	O	O	O	O
Research	research	O	O	O	O
Database	database	O	O	O	O
we	we	O	O	O	O
conducted	conducted	O	O	O	O
a	a	O	O	O	O
cohort	cohort	O	O	O	O
analysis	analysis	O	O	O	O
and	and	O	O	O	O
case-control	case-control	O	O	O	O
study	study	O	O	O	O
nested	nested	O	O	O	O
within	within	O	O	O	O
a	a	O	O	O	O
population	population	O	O	O	O
of	of	O	O	O	O
women	women	O	O	O	O
aged	aged	O	O	O	O
between	between	O	O	O	O
15	15	O	O	O	O
and	and	O	O	O	O
39	39	O	O	O	O
years	years	O	O	O	O
with	with	O	O	O	O
acne	acne	O	DISEASE	OTHERS	I
,	,	O	O	O	O
hirsutism	hirsutism	O	O	OTHERS	I
or	or	O	O	O	O
PCOS	pcos	O	DISEASE	OTHERS	I
to	to	O	O	O	O
estimate	estimate	O	O	O	O
the	the	O	O	O	O
risk	risk	O	O	O	O
of	of	O	O	O	O
VTE	vte	O	DISEASE	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
CPA/EE	cpa/ee	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
age-adjusted	age-adjusted	O	O	O	O
incidence	incidence	O	O	O	O
rate	rate	O	O	O	O
ratio	ratio	O	O	O	O
for	for	O	O	O	O
CPA/EE	cpa/ee	O	O	O	O
versus	versus	O	O	O	O
conventional	conventional	O	O	O	O
COCs	cocs	O	O	OTHERS	I
was	was	O	O	O	O
2.20	2.20	O	O	O	O
[	[	O	O	O	O
95	95	O	O	O	O
%	%	O	O	O	O
confidence	confidence	O	O	O	O
interval	interval	O	O	O	O
(	(	O	O	O	O
CI	ci	O	O	O	O
)	)	O	O	O	O
1.35	1.35	O	O	O	O
-	-	O	O	O	O
3.58	3.58	O	O	O	O
]	]	O	O	O	O
.	.	O	O	O	O

Using	using	O	O	O	O
as	as	O	O	O	O
the	the	O	O	O	O
reference	reference	O	O	O	O
group	group	O	O	O	O
women	women	O	O	O	O
who	who	O	O	O	O
were	were	O	O	O	O
not	not	O	O	O	O
using	using	O	O	O	O
oral	oral	O	O	OTHERS	I
contraception	contraception	O	O	OTHERS	I
,	,	O	O	O	O
had	had	O	O	O	O
no	no	O	O	O	O
recent	recent	O	O	O	O
pregnancy	pregnancy	O	O	O	O
or	or	O	O	O	O
menopausal	menopausal	O	O	OTHERS	I
symptoms	symptoms	O	O	OTHERS	I
,	,	O	O	O	O
the	the	O	O	O	O
case-control	case-control	O	O	O	O
analysis	analysis	O	O	O	O
gave	gave	O	O	O	O
an	an	O	O	O	O
adjusted	adjusted	O	O	O	O
odds	odds	O	O	O	O
ratio	ratio	O	O	O	O
(	(	O	O	O	O
OR(adj	or(adj	O	O	O	O
)	)	O	O	O	O
)	)	O	O	O	O
of	of	O	O	O	O
7.44	7.44	O	O	O	O
(	(	O	O	O	O
95	95	O	O	O	O
%	%	O	O	O	O
CI	ci	O	O	O	O
3.67	3.67	O	O	O	O
-	-	O	O	O	O
15.08	15.08	O	O	O	O
)	)	O	O	O	O
for	for	O	O	O	O
CPA/EE	cpa/ee	O	O	O	O
use	use	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
an	an	O	O	O	O
OR(adj	or(adj	O	O	O	O
)	)	O	O	O	O
of	of	O	O	O	O
2.58	2.58	O	O	O	O
(	(	O	O	O	O
95	95	O	O	O	O
%	%	O	O	O	O
CI	ci	O	O	O	O
1.60	1.60	O	O	O	O
-	-	O	O	O	O
4.18	4.18	O	O	O	O
)	)	O	O	O	O
for	for	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
conventional	conventional	O	O	O	O
COCs	cocs	O	O	OTHERS	I
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
We	we	O	O	O	O
have	have	O	O	O	O
demonstrated	demonstrated	O	O	O	O
an	an	O	O	O	O
increased	increased	O	O	O	O
risk	risk	O	O	O	O
of	of	O	O	O	O
VTE	vte	O	DISEASE	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
CPA/EE	cpa/ee	O	O	O	O
in	in	O	O	O	O
women	women	O	O	O	O
with	with	O	O	O	O
acne	acne	O	DISEASE	OTHERS	I
,	,	O	O	O	O
hirsutism	hirsutism	O	O	OTHERS	I
or	or	O	O	O	O
PCOS	pcos	O	DISEASE	OTHERS	I
although	although	O	O	O	O
residual	residual	O	O	O	O
confounding	confounding	O	O	O	O
by	by	O	O	O	O
indication	indication	O	O	O	O
can	can	O	O	O	O
not	not	O	O	O	O
be	be	O	O	O	O
excluded	excluded	O	O	O	O
.	.	O	O	O	O

